eureKARE is an investment company focused on financing and developing synthetic biology innovation across Europe. Driven by the belief that synthetic biology holds the key to many of the world’s most pressing health and environmental challenges, eureKARE’s experienced team is focused on harnessing Europe’s untapped leadership in the field to build the companies of the future. eureKARE is championing a new model of start-up creation and development to create a dynamic ecosystem of early and later stage ventures through its network of biotech studios. eureKARE’s studios act as a bridge between academia and industry, helping to catalyze innovations into companies with access to all the ingredients they need to grow, prosper, and bring benefits to society.
4
Total Investments
4
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Finance
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About eureKARE
Recent Investments (4)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Seed | •••••• | Nov 2022 | |
| Series C | •••••• | Jan 2022 | |
| Corporate Round | •••••• | Nov 2021 | |
| Series B | •••••• | Jul 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.